Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function (NCT06944392) | Clinical Trial Compass
RecruitingNot Applicable
Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function
United States40 participantsStarted 2025-04-11
Plain-language summary
This is a pilot study to assess using validated outcome measures how ingesting pumpkin seed oil extract supports patient bladder function in a United States population.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* All patients evaluated at Northwestern's IPHP who report bladder function consistent with overactive bladder (urinary urgency, with or without urinary frequency more than 8 times daily or nocturia, with or without urgency urinary incontinence) at their index visit, who are also willing to use a dietary supplement and not initiate additional behavioral, medication or procedural treatment for 12 weeks following pumpkin seed oil extract initiation.
Exclusion Criteria:
* Patients with any of the following will be excluded from the study:
* Use of other supplements that contain pumpkin seed oil
* ā„Stage 3 pelvic organ prolapse
* Urinary post-void residual ā„150cc
* Culture-proven urinary tract infection at time of study enrollment
* Recurrent urinary tract infection
* Neurogenic bladder
* Abdominal or pelvic malignancy
* Initiation of new overactive bladder medications or supplements during study period or in the 3 months immediately preceding study enrollment
* History of surgery in the past 12 months for pelvic organ prolapse, stress urinary incontinence, urgency urinary incontinence, or fecal or flatal incontinence
* Patient's primary language is not English